The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases
β Scribed by Carey K. Anders; Allison M. Deal; C. Ryan Miller; Carmen Khorram; Hong Meng; Emily Burrows; Chad Livasy; Karen Fritchie; Matthew G. Ewend; Charles M. Perou; Lisa A. Carey
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 198 KB
- Volume
- 117
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND: The aim of this study was to assess the role of systemic treatment after wholeβbrain radiotherapy (WBRT) in immunohistochemically defined biological subsets of breast cancer patients with brain metastases. ## METHODS: The group of 420 consecutive breast cancer patients
## Abstract ## BACKGROUND The majority of breast cancer patients with brain metastases receive wholeβbrain radiotherapy (WBRT) and have a survival of only a few months. A short WBRT regimen would be preferable if it provides survival that is similar to that achieved with longer programs. This retr
## Abstract ## BACKGROUND Brain metastases (BM) are the most common intracranial tumors in adults. To the authors' knowledge, established prognostic factors for survival after the diagnosis of BM in breast cancer patients do not take into account HERβ2 status, which may have increasing relevance i